# US 2023/0055790 A1 · Melt-extrudable 3d printing inks

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0055790 A1
- Document ID: US20230055790A1
- Status: Published application
- Kind: A1
- Application number: 17/784,346
- Filed: 2020-12-11
- Published: 2023-02-23
- Earliest claimed: 2019-12-12
- Assignees: Massachusetts Eye and Ear Infirmary; President and Fellows of Harvard College
- Applicants: Massachusetts Eye and Ear Infirmary; President and Fellows of Harvard College
- Inventors: Nicole Leah BLACK; Emily DAVIDSON; Jennifer A. LEWIS; Aaron Kyle REMENSCHNEIDER; Elliott D. KOZIN
- Web page: https://patentgrep.com/patent/US20230055790A1

## CPC

- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C08G 18/73: acyclic
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- B33Y 70/00: Materials specially adapted for additive manufacturing
- C08G 18/244: {tin salts of carboxylic acids}
- C08G 18/3228: {acyclic}
- C08G 18/4277: {Caprolactone and/or substituted caprolactone}
- C08G 18/6651: {with compounds of group C08G18/3225 or polyamines of C08G18/38}
- C08L 75/02: Polyureas
- C08L 75/06: from polyesters
- A61L 2400/08: Methods for forming porous structures using a negative form which is filled and then removed by pyrolysis or dissolution
- A61L 2430/14: for ear reconstruction or ear implants, e.g. implantable hearing aids
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- B33Y: ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

Described herein are melt-extrudable biodegradable inks for 3D-printing, methods of using the inks, and kits including the inks, to prepare implantable grafts, such as artificial tympanic membrane devices or artificial cartilage, nerve conduit, tendon, muscle tissue, or bone devices.

## Claims

### Claim 1

A melt-extrudable biodegradable ink for 3D printing, the ink comprising:
a soft segment block, and
a hard segment block,
wherein the molar ratio of soft segment block to hard segment block is in a range from 1:1.2 to 1:2.0.

### Claim 2 (depends on 1)

The melt-extrudable biodegradable ink for 3D printing of claim 1, wherein the soft segment block comprises one or more of polycaprolactone (PCL), poly(ethylene glycol) (PEG), poly(hexamethylene carbonate) (PHC), poly(ethylene oxide) (PEO), poly(propylene oxide) (PPO), polylactide, (PLA), polyglycolide (PGA), poly(hydroxybutyrate) (P3HB and P4HB), poly(citric acid), poly(sebacic acid), amino acids, or other poly(ester), poly(ether), poly(carbonate), poly (tetramethylene oxide) (PTMO), poly(propylene fumarate) (PPF), and poly(amide) soft segments.

### Claim 3 (depends on 2)

The melt-extrudable biodegradable ink for 3D printing of claim 2, wherein the soft segment block is a diol formed from one or more of polycaprolactone (PCL), poly(ethylene glycol) (PEG), poly(hexamethylene carbonate) (PHC), poly(ethylene oxide) (PEO), poly(propylene oxide) (PPO), polylactide, (PLA), polyglycolide (PGA), poly(hydroxybutyrate) (P3HB and P4HB), poly(citric acid), poly(sebacic acid), amino acids, or other poly(ester), poly(ether), poly(carbonate), poly (tetramethylene oxide) (PTMO), poly(propylene fumarate) (PPF), and poly(amide) soft segments.

### Claim 4 (depends on 1)

The melt-extrudable biodegradable ink for 3D printing of claim 1, wherein the hard segment block comprises one or more of isophorene diisocyanate (IPDI), methyl diphenyl diisocyanate (MDI), 1-lysine diisocyanate (LDI), 1,4-butane diisocyanate (BDI), hexamethylene diisocyanate (HDI), trimethylhexamethylene diisocyanate (TMDI), ethyl diisocyanate (ELDI), methyl diisocyanate (MLDI), and 1,4-cyclohexane diisocyanate (CHDI).

### Claim at position 5

5-6. (canceled)

### Claim 7 (depends on 1)

The melt-extrudable biodegradable ink for 3D printing of claim 1, wherein the soft segment and hard segment are present in a ratio needed to make a poly(ester urethane)urea (PEUU).

### Claim 8 (depends on 1)

The melt-extrudable biodegradable ink for 3D printing of claim 1, further comprising one or more chain extenders selected from the group consisting of: ethylene glycol, 1,4-butanediol, 1,4-cyclohexanedimethanol, 1,2-ethanediamine, 1,4-butanediamine, 2-amino-1-butanol, and 2-hydroxyethyl-2-hydroxyproponoate.

### Claim 9

(canceled)

### Claim 10 (depends on 1)

The melt-extrudable biodegradable ink for 3D printing of claim 1, further comprising a fugitive porogen.

### Claim 11 (depends on 10)

The melt-extrudable biodegradable ink for 3D printing of claim 10, wherein the fugitive porogen is an oligomer including poly(ethylene glycol) or poly(propylene glycol).

### Claim 12 (depends on 10)

The melt-extrudable biodegradable ink for 3D printing of claim 10, wherein the fugitive porogen comprises one or more of pluronic, alginate, gelatin, polyacrylic acid, poly(acrylate), poly(methacrylate), poly(maleic acid), poly(ethylene oxide), acrylates, methacrylates, water-soluble salts, water-soluble proteins, water-soluble small molecules, sugars, and water-soluble polysaccharides.

### Claim 13

A melt-extrudable biodegradable ink for 3D printing, the ink comprising:
a biodegradable polymer, and
a fugitive porogen material,
wherein the fugitive porogen material is present at a weight percent of no more than 50 wt %.

### Claim 14 (depends on 13)

The melt-extrudable biodegradable ink for 3D printing of claim 13, wherein the biodegradable polymer comprises a soft segment block and a hard segment block, and
wherein the soft segment block comprises one or more of polycaprolactone (PCL), poly(ethylene glycol) (PEG), poly(hexamethylene carbonate) (PHC), poly(ethylene oxide) (PEO), poly(propylene oxide) (PPO), polylactide, (PLA), polyglycolide (PGA), poly(hydroxybutyrate) (P3HB and P4HB), poly(citric acid), poly(sebacic acid), amino acids, or other poly(ester), poly(ether), poly(carbonate), poly (tetramethylene oxide) (PTMO), poly(propylene fumarate) (PPF), and poly(amide) soft segments, and/or
wherein the hard segment block comprises one or more of isophorene diisocyanate (IPDI), methyl diphenyl diisocyanate (MDI), 1-lysine diisocyanate (LDI), 1,4-butane diisocyanate (BDI), hexamethylene diisocyanate (HDI), trimethylhexamethylene diisocyanate (TMDI), ethyl diisocyanate (ELDI), methyl diisocyanate (MLDI), and 1,4-cyclohexane diisocyanate (CHDI).

### Claim at position 14

15-16. (canceled)

### Claim 17 (depends on 13)

The melt-extrudable biodegradable ink for 3D printing of claim 13, wherein the biodegradable polymer comprises one or more of hyaluronic acid (HA), poly(glycerol sebacate), poly(l,8-octanediol citrate), poly(limonene thioether), poly (lactic-co-glycolic acid) (PLGA), polyurethane, poly(ester urethane)urea (PEUU), poly(carbonate urethane) urea (PECUU), collagen, fibrin, nylon, and silk.

### Claim 18 (depends on 13)

The melt-extrudable biodegradable ink for 3D printing of claim 13, wherein the fugitive porogen is an oligomer including poly(ethylene glycol) or poly(propylene glycol).

### Claim 19 (depends on 13)

The melt-extrudable biodegradable ink for 3D printing of claim 13, wherein the fugitive porogen comprises one or more of pluronic, alginate, gelatin, polyacrylic acid, poly(acrylate), poly(methacrylate), poly(maleic acid), poly(ethylene oxide), acrylates, methacrylates, water-soluble salts, water-soluble proteins, water-soluble small molecules, sugars, and water-soluble polysaccharides.

### Claim 20 (depends on 13)

A graft, comprising the melt-extrudable biodegradable ink for 3D printing of claim 13.

### Claim 21 (depends on 20)

A method of fabricating the graft of claim 20, the method comprising melt-extruding the melt-extrudable biodegradable ink for 3D printing through a nozzle from a heated extrusion print head.

### Claim at position 20

22-23. (canceled)

### Claim 24 (depends on 20)

A method of implanting the graft of claim 20 into a patient to heal or augment a tympanic membrane or to replace a missing tympanic membrane or missing portion thereof, the method comprising:
accessing the damaged or missing tympanic membrane;
obtaining an appropriately sized and configured graft in the form of an artificial tympanic membrane device; and
securing the artificial tympanic membrane device to seal the a damaged portion of the tympanic membrane or to replace the missing tympanic membrane or missing portion thereof.

### Claim 25 (depends on 24)

The method of claim 24, wherein the graft further comprises a cellular adhesion and/or a cell invasion-inducing material to promote tissue adhesion and cell growth.

### Claim 26 (depends on 24)

The method of claim 24, wherein the graft promotes cellular alignment and deposition of extracellular matrix proteins along the print path via anisotropic topographical, chemical, or mechanical properties present in the graft.

### Claim 27 (depends on 20)

A method of implanting the graft of claim 20 into a patient to heal or augment vasculature tissue, cartilage, a nerve conduit, a tendon, muscle tissue, or a bone or to replace a missing portion of vasculature tissue, cartilage, nerve conduit, tendon, muscle tissue, or bone, the method comprising:
accessing the damaged or missing vasculature tissue, cartilage, nerve conduit, tendon, muscle tissue, or bone;
obtaining an appropriately sized and configured graft in the form of an artificial vasculature tissue, cartilage, nerve conduit, tendon, muscle tissue, or bone device; and
securing the artificial cartilage, nerve conduit, tendon, muscle tissue, or bone device to seal a damaged portion of the vasculature tissue, cartilage, nerve conduit, tendon, muscle tissue, or bone, or to replace the missing portion of cartilage, nerve conduit, tendon, muscle tissue, or bone.
